The p53/miR-34 axis in development and disease

Journal of Molecular Cell Biology

Volumn 6, Issue 3, 2014, Pages 214-230

  Rokavec, Matjaz ^a   Li, Huihui ^a   Jiang, Longchang ^a   Hermeking, Heiko ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

cancer; metastasis; miR 34; miR 34a; miR 34b c; p53; tumor suppression

Indexed keywords

MICRORNA; MICRORNA 34A; PROTEIN P53;

CANCER STEM CELL; CELL CYCLE; METABOLIC REGULATION; METASTASIS; NEOPLASM; PROTEIN FUNCTION; REVIEW; TUMOR INVASION; ANIMAL; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; EMBRYONIC DEVELOPMENT; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MICRORNAS; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84901704452     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mju003     Document Type: Review

References (193)

1. Abu-Halima, M., Hammadeh, M., Schmitt, J., et al. (2013). Altered microRNA expression profiles of human spermatozoa in patients with different spermato-genic impairments. Fertil. Steril. 99, 1249-1255. e16.
2. Agostini, M., Tucci, P., Steinert, J. R., et al. (2011). microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc. Natl Acad. Sci. USA 108, 21099-21104.
3. Ahn, Y. H., Gibbons, D. L., Chakravarti, D., et al. (2012). ZEB1 drivesprometastatic actin cytoskeletal remodeling by downregulating miR-34a expression. J. Clin. Invest. 122, 3170-3183.
4. Akbas, F., Coskunpinar, E., Aynaci, E., et al. (2012). Analysisofserum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease. Exp. Lung Res. 38, 286-294.
5. Aranha, M. M., Santos, D. M., Solá, S., et al. (2011). miR-34a regulates mouse neural stem cell differentiation. PLoS One 6, e21396.
6. Bader, A. G. (2012). miR-34-a microRNA replacement therapy is headed to the clinic. Front. Genet. 3, 120.
7. Bae, Y., Yang, T., Zeng, H.-C., et al. (2012). miRNA-34c regulates Notch signaling during bone development. Hum. Mol. Genet. 21, 2991-3000.
8. Bai, X.-Y., Ma, Y., Ding, R., et al. (2011). miR-335 and miR-34a promoterenal senescence by suppressing mitochondrial antioxidative enzymes. J. Am. Soc. Nephrol. 22, 1252-1261.
9. Bao, J., Li, D., Wang, L., et al. (2012). MicroRNA-449 and microRNA-34b/c function redundantly in murine testes by targeting E2F transcription factor-retinoblastoma protein (E2F-pRb) pathway. J. Biol. Chem. 287, 21686-21698.
10. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
11. Bernardi, C., Soffientini, U., Piacente, F., et al. (2013). Effects of microRNAs on fucosyltransferase 8 (FUT8) expression in hepatocarcinoma cells. PLoS One 8, e76540.
12. Bernardo, B. C., Gao, X.-M., Winbanks, C. E., et al. (2012). Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc. Natl Acad. Sci. USA 109, 17615-17620.
13. Bommer, G. T., Gerin, I., Feng, Y., et al. (2007). p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17, 1298-1307. (Pubitemid 47176893)
14. Boon, R. A., Iekushi, K., Lechner, S., et al. (2013). MicroRNA-34a regulates cardiac ageing and function. Nature 495, 107-110.
15. Bouhallier, F., Allioli, N., Lavial, F., et al. (2010). Role of miR-34c microRNA in the late steps of spermatogenesis. RNA 16, 720-731.
16. Brosh, R., and Rotter, V. (2009). When mutants gain new powers: news from the mutant p53 field. Nat. Rev. Cancer 9, 701-713.
17. Bu, P., Chen, K.-Y., Chen, JH, Joyce, H., et al. (2013). A microRNA miR-34a-regulated bimodal switch targets notch in colon cancer stem cells. Cell Stem Cell 12, 602-615.
18. Burk, U., Schubert, J., Wellner, U., et al. (2008). A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9, 582-589. (Pubitemid 351772923)
19. Cao, W., Fan, R., Wang, L., et al. (2013). Expression and regulatory function of miRNA-34a in targetingsurvivin in gastric cancercells. Tumour Biol. 34, 963-971.
20. Castro, R. E., Ferreira, D. M., Afonso, M. B., et al. (2013). miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. J. Hepatol. 58, 119-125.
21. Cermelli, S., Ruggieri, A., Marrero, J. A., et al. (2011). Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 6, e23937.
22. Chang, T.-C., Wentzel, E. A., Kent, O. A., et al. (2007). Transactivation of miR-34a by p53 broadly influences gene expression and promotesapoptosis. Mol. Cell 26, 745-752. (Pubitemid 46856245)
23. Chang, S.-J., Weng, S.-L., Hsieh, J.-Y., et al. (2011). MicroRNA-34a modulates genes involved in cellular motility and oxidative phosphorylation in neural precursors derived from human umbilical cord mesenchymal stem cells. BMC Med. Genomics 4, 65.
24. Chen, Q. R., Yu, L. R., Tsang, P., et al. (2011). Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a. J. Proteome Res. 10, 479-487.
25. Cheung, O., Puri, P., Eicken, C., et al. (2008). Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 48, 1810-1820.
26. Chien, K. H., Chen, S. J., Liu, J. H., et al. (2013). Correlation between microRNA-34a levels and lens opacity severity in age-related cataracts. Eye 27, 883-888.
27. Choi, Y. J., Lin, C.-P., Ho, J. J., et al. (2011). miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat. Cell Biol. 13, 1353-1360.
28. Choi, S.-E., Fu, T., Seok, S., et al. (2013). Elevated microRNA-34a in obesity reduces NAD(+) levels and SIRT1 activity by directly targeting NAMPT. Aging Cell 12, 1062-1072.
29. Christoffersen, N. R., Shalgi, R., Frankel, L. B., et al. (2010). p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ. 17, 236-245.
30. Cole, K. A., Attiyeh, E. F., Mosse, Y. P., et al. (2008). A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol. Cancer Res. 6, 735-742.
31. Concepcion, C. P., Han, Y.-C., Mu, P., et al. (2012). Intact p53-dependent responses in miR-34-deficient mice. PLoS Genet. 8, e1002797.
32. Corney, D. C., Flesken-Nikitin, A., Godwin, A. K., et al. (2007). MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in controlof cell proliferation and adhesion-independent growth. Cancer Res. 67, 8433-8438. (Pubitemid 47437414)
33. Craig, V. J., Cogliatti, S. B., Imig, J., et al. (2011). Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1. Blood 117, 6227-6236.
34. Craig, V. J., Tzankov, A., Flori, M., et al. (2012). Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia 26, 2421-2424.
35. Dang, Y., Luo, D., Rong, M., et al. (2013). Underexpression ofmiR-34a inhepato-cellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET. PLoS One 8, e61054.
36. + tumor-propagating cells andsupports neuraldifferentiationinmedulloblastoma. PLoS One6, e24584.
37. De Craene, B., and Berx, G. (2013). Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 13, 97-110.
38. Dickson, J. R., Kruse, C., Montagna, D. R., et al. (2013). Alternative polyadenyla-tion and miR-34 family members regulate tau expression. J. Neurochem. 127, 739-749.
39. Dong, P., Karaayvaz, M., Jia, N., et al. (2013). Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Oncogene 32, 3286-3295.
40. Du, R., Sun, W., Xia, L., et al. (2012). Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. PLoS One 7, e30771.
41. Duan, W., Xu, Y., Dong, Y., et al. (2013). Ectopic expression ofmiR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway. J. Radiat. Res. 54, 611-619.
42. Eichelser, C., Flesch-Janys, D., Chang-Claude, J., et al. (2013). Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression. Clin. Chem. 59, 1489-1496
43. el-Deiry, W. S., Kern, S. E., Pietenpol, J. A., et al. (1992). Definition of a consensus binding site for p53. Nat. Genet. 1, 45-49.
44. Fan, F., Sun, A., Zhao, H., et al. (2013). MicroRNA-34a promotes cardiomyocyte apoptosis post myocardial infarction through down-regulating aldehyde de-hydrogenase 2. Curr. Pharm. Des. 19, 4865-4873.
45. Fantin, V. R., St-Pierre, J., and Leder, P. (2006). Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9, 425-434. (Pubitemid 43832190)
46. Feng, Y., Huang, W., Meng, W., et al. (2014). Heatshock improvessca-1stemcells survival and directs ischemic cardiomyocytes towards a prosurvival phenotype via exosomal transfer: a critical role for HSF1/miR-34a/HSP70 pathway. Stem Cells 32, 462-472.
47. Fineberg, S. K., Datta, P., Stein, C. S., et al. (2012). MiR-34a represses Numbl in murine neural progenitor cells and antagonizes neuronal differentiation. PLoS One 7, e38562.
48. Friedman, R. C., Farh, K. K., Burge, C. B., et al. (2009). Most mammalian mRNAsare conserved targets of microRNAs. Genome Res. 19, 92-105.
49. Fu, T., Choi, S.-E., Kim, D.-H., et al. (2012). Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting amembrane cor-eceptor b-Klotho. Proc. Natl Acad. Sci. USA 109, 16137-16142.
50. Fujita, Y., Kojima, K., Hamada, N., et al. (2008). Effects ofmiR-34aoncell growth and chemoresistance in prostate cancer PC3 cells. Biochem. Biophys. Res. Commun. 377, 114-119.
51. Gallardo, E., Navarro, A., Viñolas, N., et al. (2009). miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis 30, 1903-1909.
52. Garofalo, M., Jeon, Y. J., Nuovo, G. J., et al. (2013). MiR-34a/c-dependent PDGFR-alpha/beta downregulation inhibits tumorigenesis and enhances TRAIL-induced apoptosis in lung cancer. PLoS One 8, e67581.
53. Gaughwin, P. M., Ciesla, M., Lahiri, N., et al. (2011). Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum. Mol. Genet. 20, 2225-2237.
54. Goh, A. M., Coffill, C. R., and Lane, D. P. (2011). The role of mutant p53 in human cancer. J. Pathol. 223, 116-126.
55. Gregory, P. A., Bert, A. G., Paterson, E. L., et al. (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593-601. (Pubitemid 351627379)
56. Guo, Y., Li, S., Qu, J., et al. (2011). MiR-34a inhibits lymphatic metastasis potential of mouse hepatoma cells. Mol. Cell. Biochem. 354, 275-282.
57. Hagiwara, K., Kosaka, N., Yoshioka, Y., et al. (2012). Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity. Sci. Rep. 2, 314.
58. Hahn, S., Jackstadt, R., Siemens, H., et al. (2013). SNAIL and miR-34a feedforward regulation ofZNF281/ZBP99 promotes epithelial-mesenchymal transition. EMBO J. 32, 3079-3095.
59. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
60. Haramati, S., Navon, I., Issler, O., et al. (2011). MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34. J. Neurosci. 31, 14191-14203.
61. Hashimi, S. T., Fulcher, J. A., Chang, M. H., et al. (2009). MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1in the coordinate regulation of dendritic cell differentiation. Blood 114, 404-414.
62. He, L., He, X., Lim, L. P., et al. (2007). A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134. (Pubitemid 47014436)
63. Healy, N. A., Heneghan, H. M., Miller, N., et al. (2012). Systemic miRNAsaspoten-tial biomarkers for malignancy. Int. J. Cancer 131, 2215-2222.
64. Hermeking, H. (2007). p53 enters the microRNAworld. Cancer Cell 12, 414-418.
65. Hermeking, H. (2012). MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat. Rev. Cancer 12, 613-626.
66. Hermeking, H., Lengauer, C., Polyak, K., et al. (1997). 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1, 3-11. (Pubitemid 127376388)
67. Hu, K., Xie, Y.-Y., Zhang, C., et al. (2012). MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apop-tosis post-status epilepticus. BMC Neurosci. 13, 115.
68. Hui, C., Yujie, F., Lijia, Y., et al. (2012). MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3, 6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis. Breast Cancer Res. 14, R80.
69. Hwang, C.-I., Matoso, A., Corney, D. C., et al. (2011). Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc. Natl Acad. Sci. USA 108, 14240-14245.
70. Ichimura, A., Ruike, Y., Terasawa, K., et al. (2010). MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells. Mol. Pharmacol. 77, 1016-1024.
71. Ito, T., Yagi, S., and Yamakuchi, M. (2010). MicroRNA-34a regulationof endothe-lial senescence. Biochem. Biophys. Res. Commun. 398, 735-740.
72. Jain, A. K., Allton, K., Iacovino, M., et al. (2012). p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol. 10, e1001268.
73. Ji, Q., Hao, X., Meng, Y., et al. (2008). Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 8, 266.
74. Ji, Q., Hao, X., Zhang, M., et al. (2009). MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 4, e6816.
75. Ji, X., Wang, Z., Geamanu, A., et al. (2012). Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells. Int. J. Cancer 131, 2668-2677.
76. Kalimutho, M., Di Cecilia, S., Del Vecchio Blanco, G., et al. (2011). Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer. Br. J. Cancer 104, 1770-1778.
77. Kaller, M., Liffers, S.-T., Oeljeklaus, S., et al. (2011). Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis. Mol. Cell. Proteomics 10, M111.010462.
78. Kang, J., Kim, E., Kim, W., et al. (2013). Rhamnetin and cirsiliol induce radiosen-sitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines. J. Biol. Chem. 288, 27343-27357.
79. Kashat, M., Azzouz, L., Sarkar, S. H., et al. (2012). Inactivation ofAR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness. Am. J. Transl. Res. 4, 432-442.
80. Kim, N. H., Kim, H. S., Kim, N. G., et al. (2011a). p53and microRNA-34 aresuppres-sors of canonical Wnt signaling. Sci. Signal. 4, ra71.
81. Kim, N. H., Kim, H. S., Li, X.-Y., et al. (2011b). A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J. Cell Biol. 195, 417-433.
82. Kim, T., Veronese, A., Pichiorri, F., et al. (2011c). p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J. Exp. Med. 208, 875-883.
83. Kim, H.-R., Roe, J.-S., Lee, J.-E., et al. (2012). A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH. Biochem. Biophys. Res. Commun. 418, 682-688.
84. Kim, H.-R., Roe, J.-S., Lee, J.-E., et al. (2013a). p53 regulates glucose metabolism by miR-34a. Biochem. Biophys. Res. Commun. 437, 225-231.
85. Kim, N. H., Cha, Y. H., Kang, S. E., et al. (2013b). p53regulatesnuclear GSK-3levels through miR-34-mediated Axin2 suppression in colorectal cancer cells. Cell Cycle 12, 1578-1587.
86. Kojima, K., Fujita, Y., Nozawa, Y., et al. (2010). MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms. Prostate 70, 1501-1512.
87. Kong, L., Zhu, J., Han, W., et al. (2011). Significance of serum microRNAs in pre-diabetes and newlydiagnosed type2diabetes:aclinical study. Acta Diabetol. 48, 61-69.
88. Kong, D., Heath, E., Chen, W., et al. (2012). Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment. Am. J. Transl. Res. 4, 14-23.
89. Kress, T. R., Cannell, I. G., Brenkman, A. B., et al. (2011). The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis. Mol. Cell 41, 445-457.
90. Krol, J., Loedige, I., and Filipowicz, W. (2010). The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11, 597-610.
91. Kumazaki, M., Noguchi, S., Yasui, Y., et al. (2013). Anti-cancer effectsof naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells. J. Nutr. Biochem. 24, 1849-1858.
92. Lane, D., and Levine, A. (2010). p53 Research: the past thirty years and the next thirty years. Cold Spring Harb. Perspect. Biol. 2, a000893.
93. Lee, J., Padhye, A., Sharma, A., et al. (2010). A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition. J. Biol. Chem. 285, 12604-12611.
94. Lee, Y. L., Peng, Q., Fong, S. W., et al. (2012). Sirtuin 1 facilitates generation of induced pluripotent stem cells from mouse embryonic fibroblasts through the miR-34a and p53 pathways. PLoS One 7, e45633.
95. Lefort, K., Brooks, Y., Ostano, P., et al. (2013). A miR-34a-SIRT6 axisin the squa-mous cell differentiation network. EMBO J. 32, 2248-2263.
96. Levine, A. J., Finlay, C. A., and Hinds, P. W. (2004). P53isatumor suppressor gene. Cell 116 (2 Suppl), S67-S69, 1 p following S69.
97. Li, N., Fu, H., Tie, Y., et al. (2009a). miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett. 275, 44-53.
98. Li, S., Chen, X., Zhang, H., et al. (2009b). Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. J. Lipid Res. 50, 1756-1765.
99. Li, Y., Guessous, F., Zhang, Y., et al. (2009c). MicroRNA-34ainhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 69, 7569-7576.
100. Li, W.-Q., Chen, C., Xu, M.-D., et al. (2011a). The rno-miR-34 familyisupregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J. 278, 1522-1532.
101. Li, X., Khanna, A., Li, N., et al. (2011b). Circulatory miR34aas an RNAbased, non-invasive biomarker for brain aging. Aging 3, 985-1002.
102. Li, T., Kon, N., Jiang, L., et al. (2012). Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 149, 1269-1283.
103. Liang, X., Zhou, D., Wei, C., et al. (2012). MicroRNA-34c enhances murine male germ cell apoptosis through targeting ATF1. PLoS One 7, e33861.
104. Liu, C., Kelnar, K., Liu, B., et al. (2011). The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 17, 211-215.
105. Liu, N., Landreh, M., Cao, K., et al. (2012a). The microRNA miR-34 modulates aging and neurodegeneration in Drosophila. Nature 482, 519-523.
106. Liu, W. M., Pang, R. T. K., Chiu, P. C. N., et al. (2012b). Sperm-borne microRNA-34c is required for the first cleavage division in mouse. Proc. Natl Acad. Sci. USA 109, 490-494.
107. Lodygin, D., Tarasov, V., Epanchintsev, A., et al. (2008). Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7, 2591-2600.
108. Lovis, P., Roggli, E., Laybutt, D. R., et al. (2008). Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 57, 2728-2736.
109. Lujambio, A., Calin, G. A., Villanueva, A., et al. (2008). A microRNA DNA methyla-tion signature for human cancer metastasis. Proc. Natl Acad. Sci. USA 105, 13556-13561.
110. Mackiewicz, M., Huppi, K., Pitt, J. J., et al. (2011). Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA. Breast Cancer Res. Treat. 130, 663-679.
111. Majid, S., Dar, A. A., Saini, S., et al. (2013). miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Clin. Cancer Res. 19, 73-84.
112. Mandke, P., Wyatt, N., Fraser, J., et al. (2012). MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame. PLoS One 7, e42034.
113. Mani, S. A., Guo, W., Liao, M. J., et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715. (Pubitemid 351636299)
114. Marshall, G. M., Liu, P. Y., Gherardi, S., et al. (2011). SIRT1 promotes N-Myc onco-genesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability. PLoS Genet. 7, e1002135.
115. Matsumoto, S., Sakata, Y., Suna, S., et al. (2013). Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ. Res. 113, 322-326.
116. Menssen, A., Hydbring, P., Kapelle, K., et al. (2012). The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. Proc. Natl Acad. Sci. USA 109, E187-E196.
117. Menssen, A., and Hermeking, H. (2012). c-MYC and SIRT1 locked in a vicious cycle. Oncotarget 3, 112-113.
118. Miñones-Moyano, E., Porta, S., Escaraḿis, G., et al. (2011). MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum. Mol. Genet. 20, 3067-3078.
119. Miyashita, T., Krajewski, S., Krajewska, M., et al. (1994). Tumorsuppressorp53is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9, 1799-1805. (Pubitemid 24163411)
120. Mudduluru, G., Ceppi, P., Kumarswamy, R., et al. (2011). RegulationofAxl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer. Oncogene 30, 2888-2899.
121. Nakano, K., and Vousden, K. H. (2001). PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7, 683-694. (Pubitemid 32706359)
122. Navarro, F., Gutman, D., Meire, E., et al. (2009). miR-34a contributestomegakar-yocytic differentiation of K562 cells independently of p53. Blood 114, 2181-2192.
123. Niederer, F., Trenkmann, M., Ospelt, C., et al. (2012). Down-regulation of microRNA-34a in rheumatoid arthritis synovial fibroblasts promotes apop-tosis resistance. Arthritis Rheum. 64, 1771-1779.
124. Nugent, M., Miller, N., and Kerin, M. J. (2012). Circulating miR-34a levels are reduced in colorectal cancer. J. Surg. Oncol. 106, 947-952.
125. Oren, M. (2003). Decision making by p53: life, death and cancer. Cell Death Differ. 10, 431-442. (Pubitemid 36626355)
126. Ostling, P., Leivonen, S.-K., Aakula, A., et al. (2011). Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. Cancer Res. 71, 1956-1967.
127. Pang, R. T., Leung, C. O., Lee, C.-L., et al. (2013). MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1. BMC Cancer 13, 25.
128. Pasquinelli, A. E. (2012). MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat. Rev. Genet. 13, 271-282.
129. Petitjean, A., Mathe, E., Kato, S., et al. (2007). Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum. Mutat. 28, 622-629. (Pubitemid 46744292)
130. Pigazzi, M., Manara, E., Baron, E., et al. (2009). miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. Cancer Res. 69, 2471-2478.
131. Pramanik, D., Campbell, N. R., Karikari, C., et al. (2011). Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol. Cancer Ther. 10, 1470-1480.
132. Pulikkan, J. A., Peramangalam, P. S., Dengler, V., et al. (2010). C/EBPa regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood 116, 5638-5649.
133. Rao, D. S., O'Connell, R. M., Chaudhuri, A. A., et al. (2010). MicroRNA-34a per- turbsBlymphocytedevelopmentbyrepressingtheforkheadboxtranscription factor Foxp1. Immunity 33, 48-59.
134. Raver-Shapira, N., Marciano, E., Meiri, E., et al. (2007). Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26, 731-743. (Pubitemid 46856247)
135. Rivlin, N., Brosh, R., Oren, M., et al. (2011). Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis. Genes Cancer 2, 466-474.
136. Rokavec, M., Öner, M. G., Li, H., et al. (2014). IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J. Clin. Invest. 124, 1853-1867.
137. Roth, C., Rack, B., Müller, V., et al. (2010). Circulating microRNAsasblood-based markersfor patients with primaryand metastatic breast cancer. BreastCancer Res. 12, R90.
138. Roy, S., Levi, E., Majumdar, A. P., et al. (2012). Expression of miR-34 is lost in colon cancer whichcanbere-expressedbyanovelagent CDF. J. Hematol. Oncol. 5, 58.
139. Sano, T., Reynolds, J. P., Jimenez-Mateos, E. M., et al. (2012). MicroRNA-34a upre-gulation during seizure-induced neuronal death. Cell Death Dis. 3, e287.
140. Shen, Z., Zhan, G., Ye, D., et al. (2012). MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinomaby targeting the antiapoptotic gene survi-vin. Med. Oncol. 29, 2473-2480.
141. Siemens, H., Jackstadt, R., Hunten, S., et al. (2011). miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 10, 4256-4271.
142. Siemens, H., Jackstadt, R., Kaller, M., et al. (2013a). Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness. Oncotarget 4, 1399-1415.
143. Siemens, H., Neumann, J., Jackstadt, R., et al. (2013b). DetectionofmiR-34a promoter methylation in combination with elevated expression of c-Met and b-catenin predicts distant metastasis of colon cancer. Clin. Cancer Res. 19, 710-720.
144. Silber, J., Jacobsen, A., Ozawa, T., et al. (2012). miR-34a repression in proneural malignantgliomasupregulatesexpressionofitstarget PDGFRA and promotes tumorigenesis. PLoS One 7, e33844.
145. Soni, K., Choudhary, A., Patowary, A., et al. (2013). miR-34 is maternally inherited in Drosophila melanogaster and Danio rerio. Nucleic Acids Res. 41, 4470-4480.
146. Sotillo, E., Laver, T., Mellert, H., et al. (2011). Myc overexpression brings out unexpected antiapoptotic effects of miR-34a. Oncogene 30, 2587-2594.
147. Sukata, T., Sumida, K., Kushida, M., et al. (2011). Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages. Toxicol. Lett. 200, 46-52.
148. Sun, F., Fu, H., Liu, Q., et al. (2008). Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett. 582, 1564-1568.
149. Suzuki, H. I., Yamagata, K., Sugimoto, K., et al. (2009). Modulation of microRNA processing by p53. Nature 460, 529-533.
150. Suzuki, H., Yamamoto, E., Nojima, M., et al. (2010). Methylation- associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis 31, 2066-2073.
151. Tabuchi, T., Satoh, M., Itoh, T., et al. (2012). MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression. Clin. Sci. 123, 161-171.
152. Tarasov, V., Jung, P., Verdoodt, B., et al. (2007). Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6, 1586-1593. (Pubitemid 47327945)
153. Tazawa, H., Tsuchiya, N., Izumiya, M., et al. (2007). Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl Acad. Sci. USA 104, 15472-15477. (Pubitemid 47502941)
154. Tivnan, A., Tracey, L., Buckley, P. G., et al. (2011). MicroRNA-34aisapotenttumor suppressor molecule in vivo in neuroblastoma. BMC Cancer 11, 33.
155. Toiyama, Y., Hur, K., Tanaka, K., et al. (2013). SerummiR- 200cisanovelprognos-tic and metastasis-predictive biomarker in patients with colorectal cancer. Ann. Surg. doi: 10. 1097/SLA. 0b013e3182a6909d.
156. Toyota, M., Suzuki, H., Sasaki, Y., et al. (2008). Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 68, 4123-4132.
157. Tsai, J. H., Donaher, J. L., Murphy, D. A., et al. (2012). Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22, 725-736.
158. Vinall, R. L., Ripoll, A. Z., Wang, S., et al. (2012). MiR-34achemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status. Int. J. Cancer 130, 2526-2538.
159. Vogelstein, B., Lane, D., and Levine, A. J. (2000). Surfingthe p53 network. Nature 408, 307-310.
160. Vogt, M., Munding, J., Gruner, M., et al. (2011). Frequent concomitant inactiva-tion of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cellcarcinomas and soft tissuesarco-mas. Virchows Arch. 458, 313-322.
161. Wan, M., Gao, B., Sun, F., et al. (2012). microRNA miR-34a regulates cytodiffer-entiation and targets multi-signaling pathways in human dental papilla cells. PLoS One 7, e50090.
162. Wang, Z., and Burke, P. A. (2013). The role of microRNAs in hepatocyte nuclear factor-4alpha expression and transactivation. Biochim. Biophys. Acta 1829, 436-442.
163. Wang, X., Liu, P., Zhu, H., et al. (2009). miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res. Bull. 80, 268-273.
164. Wang, C., Yang, C., Chen, X., et al. (2011a). Altered profile of seminal plasma microRNAs in the molecular diagnosis of male infertility. Clin. Chem. 57, 1722-1731.
165. Wang, Z., Chen, Z., Gao, Y., et al. (2011b). DNA hypermethylation of microRNA-34b/c has prognostic value for stage I non-small cell lung cancer. Cancer Biol. Ther. 11, 490-496.
166. Wang, Y., Guo, F., Pan, C., et al. (2012). Effects of low temperatures on proliferation-related signaling pathways in the hippocampus after traumatic brain injury. Exp. Biol. Med. 237, 1424-1432.
167. Wang, L., Fu, C., Fan, H., et al. (2013a). miR-34b regulates multiciliogenesis during organ formation in zebrafish. Development 140, 2755-2764.
168. Wang, R., Ma, J., Wu, Q., et al. (2013b). Functional roleofmiR-34 familyinhuman cancer. Curr. Drug Targets 14, 1185-1191.
169. Wang, W., Cheng, B., Miao, L., et al. (2013c). Mutant p53-R273H gains new func-tioninsustained activationofEGFR signaling viasuppressing miR-27aexpres-sion. Cell Death Dis. 4, e574.
170. Wei, J. S., Song, Y. K., Durinck, S., et al. (2008). The MYCN oncogene is a direct target of miR-34a. Oncogene 27, 5204-5213.
171. Wei, J., Shi, Y., Zheng, L., et al. (2012). miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J. Cell Biol. 197, 509-521.
172. Welch, C., Chen, Y., and Stallings, R. L. (2007). MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26, 5017-5022. (Pubitemid 47172643)
173. Wiggins, J. F., Ruffino, L., Kelnar, K., et al. (2010). Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res. 70, 5923-5930.
174. Winton, D. J. (2013). miR-34a sets the 'sweet spot' for notch in colorectal cancer stem cells. Cell Stem Cell 12, 499-501.
175. ′UTR of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites. PLoS One 6, e27438.
176. Wu, J., Wu, G., Lv, L., et al. (2012). MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Carcinogenesis 33, 519-528.
177. Wu, H., Huang, M., Lu, M., et al. (2013). Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemo-sensitivity of gastric cancer to paclitaxel. Cancer Chemother. Pharmacol. 71, 1159-1171.
178. Xia, J., Duan, Q., Ahmad, A., et al. (2012). Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Curr. Drug Targets 13, 1750-1756.
179. Xu, Q., Seeger, F. H., Castillo, J., et al. (2012). Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease. J. Am. Coll. Cardiol. 59, 2107-2117.
180. Yamada, H., Suzuki, K., Ichino, N., et al. (2013). Associationsbetween circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. Clin. Chim. Acta 424, 99-103.
181. Yamakuchi, M., Ferlito, M., and Lowenstein, C. J. (2008). miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl Acad. Sci. USA 105, 13421-13426.
182. Yan, K., Gao, J., Yang, T., et al. (2012). MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS One 7, e33778.
183. Yang, P., Li, Q.-J., Feng, Y., et al. (2012). TGF-b-miR-34a-CCL22 signaling-induced Tregcell recruitmentpromotesvenousmetastasesofHBV-positive hepatocel-lular carcinoma. Cancer Cell 22, 291-303.
184. Yang, J., Chen, D., He, Y., et al. (2013a). MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9. Age 35, 11-22.
185. Yang, S., Li, Y., Gao, J., et al. (2013b). MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Oncogene 32, 4294-4303.
186. Yates, L. A., Norbury, C. J., and Gilbert, R. J. (2013). The long and short of microRNA. Cell 153, 516-519.
187. Yu, F., Jiao, Y., Zhu, Y., et al. (2012). MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells. J. Biol. Chem. 287, 465-473.
188. Yu, M., Mu, H., Niu, Z., et al. (2014). miR-34c enhances mouse spermatogonial stem cells differentiation by targeting Nanos2. J. Cell. Biochem. 115, 232-242.
189. Zhang, S., Yu, M., Liu, C., et al. (2012). MIR-34cregulatesmouse embryonic stem cells differentiation into male germ-like cells through RARg. Cell Biochem. Funct. 30, 623-632.
190. Zhao, T., Li, J., andChen, A. F. (2010). MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am. J. Physiol. Endocrinol. Metab. 299, E110-E116.
191. Zhao, G., Guo, J., Li, D., et al. (2013a). MicroRNA-34a suppresses cell proliferation by targeting LMTK3 in human breast cancer MCF-7 cell line. DNA Cell Biol. 32, 699-707.
192. Zhao, H., Ma, B., Wang, Y., et al. (2013b). miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44. Oncol. Rep. 29, 1027-1036.
193. Zovoilis, A., Agbemenyah, H. Y., Agis-Balboa, R. C., et al. (2011). microRNA-34c is a novel target to treat dementias. EMBO J. 30, 4299-4308.